Literature DB >> 8955541

Relationship of obsessive-compulsive symptomatology to anxiety, depression and schizotypy in a clinical population.

R M Norman1, F Davies, A K Malla, L Cortese, I R Nicholson.   

Abstract

The relationship of obsessive-compulsive symptomatology to anxiety disorders, mood disorders and schizophrenia continues to be controversial. In a sample of 117 psychiatric out-patients, we examined the relationship of obsessive-compulsive symptomatology to indices of anxiety, depression and schizotypy. The relationship between obsessive-compulsive symptomatology and schizotypy was found to be significantly higher than that between obsessive-compulsive symptoms and either anxiety or depression. These findings are consistent with recent studies suggesting that there are similar cognitive deficits associated with obsessive-compulsive symptoms and schizotypy and that obsessive-compulsive disorders may be more closely aligned to the schizophrenic constellation of disorders than to anxiety disorders.

Entities:  

Mesh:

Year:  1996        PMID: 8955541     DOI: 10.1111/j.2044-8260.1996.tb01211.x

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  3 in total

1.  Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.

Authors:  A Heiden; M de Zwaan; R Frey; O Presslich; S Kasper
Journal:  J Psychiatry Neurosci       Date:  1998-05       Impact factor: 6.186

2.  Obsessive-compulsive disorder and personality disorder: evidence from the British National Survey of Psychiatric Morbidity 2000.

Authors:  Albina R Torres; Paul Moran; Paul Bebbington; Traolach Brugha; Dinesh Bhugra; Jeremy W Coid; Michael Farrell; Rachel Jenkins; Glyn Lewis; Howard Meltzer; Martin Prince
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-09-15       Impact factor: 4.328

3.  Psychotic and schizotypal symptoms in non-psychotic patients with obsessive-compulsive disorder.

Authors:  Stian Solem; Kristen Hagen; Christoffer Wenaas; Åshild T Håland; Gunvor Launes; Patrick A Vogel; Bjarne Hansen; Joseph A Himle
Journal:  BMC Psychiatry       Date:  2015-05-28       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.